Deborah Flomenhoft

549 total citations
26 papers, 348 citations indexed

About

Deborah Flomenhoft is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Deborah Flomenhoft has authored 26 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Deborah Flomenhoft's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Deborah Flomenhoft is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Deborah Flomenhoft collaborates with scholars based in United States. Deborah Flomenhoft's co-authors include Joseph R. Berger, Michael Dobbs, Robert M. Levy, Harohalli Shashidhar, Sylvia Daunert, Patrizia Pasini, Sapna K. Deo, Terrence A. Barrett, Eric Rogier and Maria E. C. Bruno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Analytical Chemistry.

In The Last Decade

Deborah Flomenhoft

19 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Flomenhoft United States 7 129 95 88 85 61 26 348
Siamaque Kazem Netherlands 10 262 2.0× 42 0.4× 22 0.3× 108 1.3× 91 1.5× 15 430
Carla Prezioso Italy 14 331 2.6× 80 0.8× 25 0.3× 105 1.2× 87 1.4× 46 600
Matthew R. Collinson-Pautz United States 6 225 1.7× 126 1.3× 81 0.9× 16 0.2× 23 0.4× 10 383
Emil Johansson Sweden 13 121 0.9× 145 1.5× 198 2.3× 155 1.8× 22 0.4× 21 584
Achintya Pal United States 7 113 0.9× 152 1.6× 50 0.6× 29 0.3× 29 0.5× 12 388
Greg Hather United States 11 76 0.6× 206 2.2× 133 1.5× 139 1.6× 137 2.2× 22 547
Analı́a Porrás United States 10 188 1.5× 115 1.2× 85 1.0× 68 0.8× 45 0.7× 15 373
Chiara Merlino Italy 12 192 1.5× 41 0.4× 20 0.2× 127 1.5× 43 0.7× 51 457
Adrienne L. McNees United States 8 147 1.1× 101 1.1× 87 1.0× 125 1.5× 9 0.1× 9 346
Elena Anzivino Italy 15 349 2.7× 58 0.6× 16 0.2× 146 1.7× 62 1.0× 29 559

Countries citing papers authored by Deborah Flomenhoft

Since Specialization
Citations

This map shows the geographic impact of Deborah Flomenhoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Flomenhoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Flomenhoft more than expected).

Fields of papers citing papers by Deborah Flomenhoft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Flomenhoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Flomenhoft. The network helps show where Deborah Flomenhoft may publish in the future.

Co-authorship network of co-authors of Deborah Flomenhoft

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Flomenhoft. A scholar is included among the top collaborators of Deborah Flomenhoft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Flomenhoft. Deborah Flomenhoft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perry, Courtney, Deborah Flomenhoft, Terrence A. Barrett, et al.. (2025). EFFICACY AND SAFETY OF UPADACITINIB FOR ACUTE SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Inflammatory Bowel Diseases. 31(Supplement_1). S72–S73.
2.
Perry, Courtney, Deborah Flomenhoft, Terrence A. Barrett, et al.. (2025). EFFICACY AND SAFETY OF UPADACITINIB FOR ACUTE SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology. 168(3). S102–S103. 1 indexed citations
3.
Hassan, Syed Adeel, et al.. (2024). UPADACITINIB RESOLVES DIARRHEA AND FECAL CALPROTECTIN ABNORMALITIES IN BUDESONIDE-DEPENDENT MICROSCOPIC COLITIS. Inflammatory Bowel Diseases. 30(Supplement_1). S91–S91.
4.
Hassan, Syed Adeel, et al.. (2024). Dual Biologic Therapy Induces Remission in Refractory Crohn’s Disease With Vedolizumab and Ustekinumab. Crohn s & Colitis 360. 7(1). otae080–otae080. 3 indexed citations
5.
Flomenhoft, Deborah, et al.. (2024). Sevelamer-Induced Ischemic Enteritis. ACG Case Reports Journal. 11(7). e01451–e01451.
6.
Hassan, Syed Adeel, Courtney Perry, Deborah Flomenhoft, et al.. (2024). UPADACITINIB AS SECOND- AND THIRD-LINE SALVAGE THERAPY FOR REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS. Gastroenterology. 166(3). S124–S125. 1 indexed citations
7.
Hassan, Syed Adeel, Courtney Perry, Deborah Flomenhoft, et al.. (2024). UPADACITINIB AS SECOND- AND THIRD-LINE SALVAGE THERAPY FOR REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS. Inflammatory Bowel Diseases. 30(Supplement_1). S90–S91. 2 indexed citations
8.
Flomenhoft, Deborah, et al.. (2023). S3204 Patient With Severe Refractory Crohn's Disease Achieved Remission on Golimumab With Guselkumab for Psoriasiform Rash and Delivered Healthy Term Infant. The American Journal of Gastroenterology. 118(10S). S2136–S2137.
9.
Perry, Courtney, et al.. (2022). INFLAMMATORY BOWEL DISEASE IN APPALACHIA: AN INVESTIGATION INTO DISPARATE OUTCOMES WITHIN THE STATE OF KENTUCKY. Gastroenterology. 162(3). S74–S75. 1 indexed citations
10.
Lee, Eun, et al.. (2022). S3474 Sevelamer-Induced Ischemic Ulcerative Colitis. The American Journal of Gastroenterology. 117(10S). e2187–e2187.
11.
Perry, Courtney, et al.. (2020). Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis. Digestive Diseases and Sciences. 66(6). 2051–2058. 17 indexed citations
12.
Perry, Courtney, Nishant Tripathi, M. A. Hussein, et al.. (2020). Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease. Therapeutic Advances in Gastroenterology. 13. 3974148109–3974148109. 25 indexed citations
13.
Pauly, Nathan, Deborah Flomenhoft, Michelle R. Lofwall, et al.. (2017). Predictors of Chronic Opioid Use in Newly Diagnosed Crohnʼs Disease. Inflammatory Bowel Diseases. 23(6). 1004–1010. 22 indexed citations
14.
Frandah, Wesam, et al.. (2016). Superior Mesenteric Artery-Duodenal Fistula Secondary to a Gunshot Wound. Baylor University Medical Center Proceedings. 29(1). 30–32. 5 indexed citations
15.
Bruno, Maria E. C., Eric Rogier, Razvan Arsenescu, et al.. (2015). Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn’s Disease and Ulcerative Colitis. Digestive Diseases and Sciences. 60(10). 2976–2984. 33 indexed citations
16.
Oz, Helieh S., Theresa S. Chen, Deborah Flomenhoft, & Willem J. de Villiers. (2013). Tu1644 Green Tea Polyphenols and Sulfasalazine Have Parallel Anti-Inflammatory Properties in Colitis Models. Gastroenterology. 144(5). S–813. 5 indexed citations
17.
Struss, Anjali K., Patrizia Pasini, Deborah Flomenhoft, Harohalli Shashidhar, & Sylvia Daunert. (2012). Investigating the effect of antibiotics on quorum sensing with whole-cell biosensing systems. Analytical and Bioanalytical Chemistry. 402(10). 3227–3236. 10 indexed citations
18.
Chung, Michael T., et al.. (2011). Atypical Clinical and Diagnostic Features in Ménétrier's Disease in a Child. SHILAP Revista de lepidopterología. 2011. 1–5. 5 indexed citations
19.
Shashidhar, Harohalli, Deborah Flomenhoft, & Vasundhara Tolia. (2008). Helicobacter pylori& beyond: pediatric peptic ulcer disease. Therapy. 6(1). 65–73. 1 indexed citations
20.
Berger, Joseph R., Robert M. Levy, Deborah Flomenhoft, & Michael Dobbs. (1998). Predictive factors for prolonged survival in acquired immunodeficiency syndrome—associated progressive multifocal leukoencephalopathy. Annals of Neurology. 44(3). 341–349. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siamaque Kazem Breakdown of academic impact, for papers by Carla Prezioso Breakdown of academic impact, for papers by Matthew R. Collinson-Pautz Breakdown of academic impact, for papers by Emil Johansson Breakdown of academic impact, for papers by Achintya Pal Breakdown of academic impact, for papers by Greg Hather Breakdown of academic impact, for papers by Analı́a Porrás Breakdown of academic impact, for papers by Chiara Merlino Breakdown of academic impact, for papers by Adrienne L. McNees Breakdown of academic impact, for papers by Elena Anzivino
Rankless by CCL
2026